Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity

Transplantation

Volumn 64, Issue 5, 1997, Pages 674-678

  Singh, Nina ^a,c   Carrigan, Donald R ^b   Gayowski, Timothy ^a   Marino, Ignazio R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Herpesvirus Diagnostics Inc   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET; GANCICLOVIR;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CLINICAL FEATURE; CYTOPENIA; DNA VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LEUKOCYTE COUNT; LEUKOPENIA; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; VIRUS ISOLATION;

ADULT; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0030984436     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709150-00002     Document Type: Article

References (38)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596.
2. Ablashi DV, Saluhuddin SZ, Josephs SF, et al. HBLV (or HHV-6) in human cell lines [Letter]. Nature 1987; 329: 207.
3. Lawrence GL, Chee M, Craxton MA, Gompels UA, Honess RW, Barrell BG. Human herpesvirus-6 is closely related to human cytomegalovirus. J Virol 1990; 64: 287.
4. Krueger GR, Klueppelberg U, Hoffman A, Ablashi DV. Clinical correlates of infection with human herpesvirus-6. In Vivo 1994; 8: 457.
5. Lusso P, Gallo RC. Human herpesvirus-6 in AIDS. Immunol Today 1995; 16: 67.
6. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065.
7. Schmidt CA, Wilborn F, Weiss K, et al. A prospective study of human herpesvirus type 6 detected by polymerase chain reaction after liver transplantation. Transplantation 1996; 61: 662.
8. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolfe P, Obert G. Longitudinal study of human herpesvirus-6 in organ transplant recipients. Clin Infect Dis 1996; 22: 171.
9. Russler SK, Tapper MH, Knox KK, Liepins A, Carrigan DR. Pneumonitis associated with coinfection by human herpes virus-6 and Legionella in an immunocompetent adult. Am J Pathol 1991; 138: 1405.
10. Knox KK, Carrigan DR. In vitro suppression of marrow progenitor cell differentiation by human herpesvirus-6 infection. J Infect Dis 1992; 165: 925.
11. Carrigan DR, Milburn G, Dienglewicz R, Kernen N, Papadopoulas E, Singh N. Diagnosis of active human herpesvirus six (HHV-6) infections in immunosuppression and patients with a rapid shell-vial assay [Abstract]. In: Abstracts of the 96th General Meeting of the American Society for Microbiology. New Orleans: American Society for Microbiology, 1996.
12. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow transplant recipient. N Engl J Med 1994; 330: 1356.
13. Knox KK, Carrigan DR. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus-6 in a bone marrow transplant recipient. Clin Infect Dis 1996; 22: 174.
14. Pitalia AK, Liu-Yin JA, Freemont AJ, Morris DJ, Fitzmaurice RJ. Immunohistological detection of human herpes virus 6 in formalin-fixed, paraffin-embedded lung tissues. J Med Virol 1993; 41: 103.
15. Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients, a randomized trial. Ann Intern Med 1994; 120: 375.
16. Chou SW, Scott KM. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant patients with primary cytomegalovirus infection. J Clin Microbiol 1990; 28: 851.
17. Carrigan DR. Human herpesvirus-6 and bone marrow transplantation [Letter]. Blood 1995; 85: 294.
18. Wilborn F, Brinkman V, Schmidt CA, Neipel F, Gelderblom H, Siegert W. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994; 83: 3052.
19. Frenkel N, Katsafanas GC, Wyatt LS, Yoshikawa T, Asano Y. Bone marrow transplant recipients harbor the B variant of human herpesvirus 6. Bone Marrow Transplant 1994; 14: 839.
20. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM. Human herpesvirus-6 infection in allogeneic bone marrow transplant recipients: evidence of a marrow suppressive role for HHV-6 in vivo. J Infect Dis 1993; 167: 735.
21. Drobyski WR, Eberle M, Majewski D, Baxter-Lowe LA. Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J Clin Microbiol 1993; 31: 1515.
22. Knox KK, Carrigan DR. Active HHV-6 infection in the lymph nodes of HIV infected patients: in vitro evidence that HHV-6 can break HIV latency. J Acquir Immune Defic Syndr 1996; 11: 370.
23. Yoshikawa T, Suga S, Asano Y, et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991; 78: 1381.
24. Carrigan DR, Knox KK. Human herpesvirus-6 (HHV-6) isolation from bone marrow: HHV-6 associated bone marrow suppression in bone marrow transplant patients. Blood 1994; 84: 3307.
25. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996; 124: 1065.
26. Singh N, Carrigan DR, Gayowski T, Singh J, Marino IR. Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation 1995; 60: 1355.
27. Rosenfeld CS, Rybka WB, Weinbaum D, Carrigan DR, Knox KK, Andrews DF. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995; 23: 626.
28. Gompels UA, Luxton J, Knox KK, Carrigan DR. Chronic bone marrow suppression in immunocompetent adult by human herpesvirus-6. Lancet 1994; 343: 735.
29. Flamand L, Stefanescu I, Ablashi DV, Menezes J. Activation of Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol 1993; 67: 6768.
30. Dockerell D, Prada J, Patel R, et al. Seroconversion to human herpesvirus-6 following liver transplantation is a predictor of cytomegalovirus disease [Abstract H12]. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996.
31. Shiraki K, Okuno T, Yamanishi K, Takahashi M. Phosphonoacetic acid inhibits replication of human herpesvirus-6. Antiviral Res 1989; 12: 311.
32. Agut H, Collandre H, Aubin JT, et al. In vitro sensitivity of human herpesvirus 6 to antiviral drugs. Res Virol 1989; 140: 219.
33. Burns WH, Sandford GR. Susceptibility of human herpesvirus to antivirals in vitro. J Infect Dis 1990; 162: 634.
34. Akesson-Johasson A, Harmenberg J, Wahren B, Linde A. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-(hydroxymethyl)butyl] guanine (2HM-HBG) and other antiviral compounds. Antimicrob Agents Chemother 1990; 34: 2417.
35. DiLuca D, Katsafanas G, Schirmer EC, Balachandran N, Frenkel N. The replication of viral and cellular DNA in human herpesvirus 6 infected cells. Virology 1990; 175: 199.
36. Streicher HZ, Hung CL, Ablashi DV, et al. In vitro inhibition of human herpesvirus-6 by phosphonoformate. J Virol Methods 1988; 21: 301.
37. Agut H, Aubin JT, Huraux JM. Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro [Letter]. J Infect Dis 1991; 163: 1382.
38. Russler SK, Tapper MA, Carrigan DR. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir [Letter]. Lancet 1989; 2: 382.